Islay Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.62K Sell
200
-1,036
-84% -$27.6K ﹤0.01% 174
2025
Q4
$30.8K Hold
1,236
0.02% 133
2025
Q3
$31.5K Hold
1,236
0.02% 146
2025
Q2
$30K Hold
1,236
0.02% 136
2025
Q1
$31.3K Hold
1,236
0.02% 127
2024
Q4
$32.8K Hold
1,236
0.02% 136
2024
Q3
$35.8K Hold
1,236
0.02% 133
2024
Q2
$34.6K Hold
1,236
0.02% 136
2024
Q1
$34.3K Sell
1,236
-105
-8% -$2.91K 0.03% 137
2023
Q4
$38.6K Buy
1,341
+105
+8% +$3.17K 0.03% 144
2023
Q3
$41K Sell
1,236
-785
-39% -$27.8K 0.03% 136
2023
Q2
$74.1K Hold
2,021
0.07% 115
2023
Q1
$82.5K Hold
2,021
0.08% 112
2022
Q4
$104K Hold
2,021
0.12% 101
2022
Q3
$88K Hold
2,021
0.1% 109
2022
Q2
$106K Hold
2,021
0.11% 121
2022
Q1
$105K Hold
2,021
0.09% 143
2021
Q4
$119K Hold
2,021
0.09% 141
2021
Q3
$87K Hold
2,021
0.07% 181
2021
Q2
$79K Hold
2,021
0.06% 180
2021
Q1
$73K Sell
2,021
-100
-5% -$3.55K 0.06% 164
2020
Q4
$78K Sell
2,121
-115
-5% -$4.22K 0.07% 153
2020
Q3
$78K Sell
2,236
-188
-8% -$6.59K 0.08% 159
2020
Q2
$75K Buy
2,424
+105
+5% +$3.57K 0.09% 145
2020
Q1
$72K Sell
2,319
-255
-10% -$8.69K 0.09% 125
2019
Q4
$96K Buy
+2,574
New +$91.7K 0.09% 103

Other funds holding PFE

Islay Capital Management's PFE Position: Q1 2026 in Review

Islay Capital Management reduced its Pfizer (PFE) stake by 84% in Q1 2026, selling an estimated $27.6K and leaving 200 shares worth $5.62K. The position accounts for ﹤0.01% of the portfolio, ranked #174.

Islay Capital Management first reported a position in PFE in Q4 2019 and has held it in 26 quarters since. The position peaked at $119K in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Islay Capital Management held 200 shares of Pfizer worth $5.62K as of Q1 2026.
  • Islay Capital Management sold 1,036 Pfizer shares in Q1 2026, an estimated $27.6K.
  • Pfizer made up ﹤0.01% of Islay Capital Management's portfolio in Q1 2026, its #174 holding.
  • Islay Capital Management first reported a position in Pfizer in Q4 2019 and has held it in 26 quarters since.
  • Islay Capital Management's Pfizer position peaked at $119K in Q4 2021.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Islay Capital Management's 13F filing for Q1 2026, filed 14 May 2026.